1 / 6

Nicotinamide Adenine Dinucleotide Market Region and Country Forecast To 2030

Growing consumer awareness and acceptance of NAD-based products for analytical applications is speculated to accelerate the growth of the segment.

gminsights
Download Presentation

Nicotinamide Adenine Dinucleotide Market Region and Country Forecast To 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nicotinamide Adenine Dinucleotide Market Is Expected To Surpass USD 1.4 Billion by 2030 Global Market Insights Inc.

  2. Overview of Nicotinamide Adenine Dinucleotide Market • The nicotinamide adenine dinucleotide market is primed to grow massively through 2030 owing to shifting beauty standards across the world. In addition, burgeoning instances of chronic diseases, along with the thriving pharmaceutical industry, are likely to augment market growth over the forecast period. • The COVID-19 pandemic encouraged business owners to secure and sustain their supply networks in order to cater to rising product demand. However, advancements in NAD supplements and products, coupled with rising awareness pertaining to product benefits, bolstered product deployment in the cosmetics and pharmaceutical industries. • Moreover, key participants in the nicotinamide adenine dinucleotide market majorly engage in expanding the range of products and undertaking extensive R&D projects to remain ahead in the competitive landscape, thereby fuelling overall business growth. In October 2022, ChromaDex, a specialist in dietary supplements, published the results of a clinical study on the safety and tolerability of NAD+ precursor nicotinamide riboside (NR). Global Market Insights Inc.

  3. Continue… • The nicotinamide adenine dinucleotide market has been categorized on the basis of grade, application, and region. • Based on grade, the nicotinamide adenine dinucleotide industry has been divided into food grade, pharmaceutical grade, and others. The food-grade NAD segment is slated to amass substantial gains over 2022-2030 as a result of various advantages of NAD supplementation, such as increased immunity & energy, improved memory, and lower blood pressure & cholesterol. • With respect to application, the NAD market has been classified into dietary supplements, pharmaceuticals, anti-aging products, and others. The others application segment is poised to witness strong growth at over 11.5% CAGR by 2030. Other applications of NAD include its use as a biochemical assay, as a cofactor in research, and so on. • In in-vitro diagnostics, nicotinamide adenine dinucleotide is used for non-glucose target detection with the use of NAD dependent enzymes. Growing consumer awareness and acceptance of NAD-based products for analytical applications is speculated to accelerate the growth of the segment. Global Market Insights Inc.

  4. Continue… • In the regional context, the Middle East & Africa NAD industry is anticipated to expand at more than 10% CAGR between 2022 and 2030. Enhanced food and beverage production, new technological developments, and the launch of innovative nutraceutical products in the MEA region are set to drive market progress. • Meanwhile, the Latin America nicotinamide adenine dinucleotide market is projected to depict over 10.5% CAGR over the next 8 years. Favorable foreign direct investments and trade policies in the pharmaceutical sector, together with advancements in the food & beverage industry, are foreseen to foster the LATAM nicotinamide adenine dinucleotide industry outlook. • Notable participants in the Nicotinamide Adenine Dinucleotide market include: Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., F. Hoffmann-La Roche Ltd, HiMedia Laboratories, NutriScience Innovations, LLC, Nutrifoods, Bontac Bio-engineering (Shenzhen) Co., Ltd., Krackeler Scientific, Shandong Lankang Bio-Technology Co., Ltd., and OYC Americas, Inc., among others. Global Market Insights Inc.

  5. Browse Full Research Report On Nicotinamide Adenine Dinucleotide Market@ http://bit.ly/3HVR0XL Request for a sample of this research report @ http://bit.ly/3Yxrdfy Global Market Insights Inc.

  6. Stay In Touch Website: www.gminsights.com Social Media: Global Market Insights Inc.

More Related